PurpleLab® provides a real-world data [lab], accelerating the discovery and adoption of healthcare innovations. View where PurpleLab insights have been leveraged.  NBC News Biden proposes weight loss drug coverage for people on Medicare and Medicaid Read Now 11/26/2024 Pharma Exec Balancing Personalized Targeting with Protecting Consumer Privacy Read Now 11/5/2024 Pharma Exec Promising Alternative Targeting…

PurpleLab® took part in HLTH 24’s Payer Insights Session on October 20th, 2024. Led by Med City New’s Arundhati Pramar, we were joined on stage by Humana’s Pankhuri Sharma and Managed Care Resource Alliance’s Darren E. Wethers for an insightful discussion on how payers can leverage claims data insights to link reimbursements and preventive care. We invite…

PurpleLab®, a leading healthcare analytics company with one of the largest medical and pharmaceutical claims databases in the US, is pleased to announce its membership in the Network Advertising Initiative (NAI), the leading self-regulatory organization dedicated to responsible data collection and use in digital advertising. In joining the NAI, PurpleLab strengthens its commitment to maintaining…

This study was run to determine if a racial disparity exists in biomarker testing for NSCLC (non-small cell lung cancer) patients. Jared Safran, PharmD, MS, Russell Robbins, MD, MBA, Maggie Mendes, Douglas Londono, PhD, Grace Kane, MS. Healthcare is evolving into precision medicine or what the FDA refers to as personalized medicine1. This targeted approach…

This study was run to evaluate whether provider specialty is a driver for biosimilar adoption, defined as adoption probability difference (APD). Diane Faraone, PharmD, Russell Robbins, MD, MBA, Grace Kane, MS, Douglas Londono, PhD.  The US biologics market has significantly expanded in recent years; projected to reach $62 billion in prescription drug spend by 2025. Biosimilar…

Study is to assess the SARS-CoV-2 antibody levels over time (2021-2022), measured with the Elecsys Anti-SARS-COV-2 S assay, in the real-world setting, and assess the association between them and subsequent COVID-19 outcomes. Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon presented a poster during ISPE 2024. The objective of this…

 PurpleLab®, the healthcare analytics platform with one of the largest medical and pharmaceutical databases in the United States, announced today the introduction of Audience Builder, a new solution for advertisers that simplifies the use of complex healthcare data. This planning tool is designed specifically to meet the unique needs of advertisers and digital media buyers. …

The company announced the introduction of Alerts to empower stakeholders in the healthcare industry with the most updated and easy-to-understand insights. Wayne, Pennsylvania. Monday, June 3, 2024 – PurpleLab®, a healthcare analytics company that holds one of the largest medical and pharmaceutical claims databases in the US, announced the launch of Alerts today, adding a…

Higher SARS-COV-2 spike antibody levels are associated with reduced risk of subsequent symptomatic and severe COVID-19. Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon from Roche Information Solutions, Roche Diagnostics GmbH, Roche Diagnostics Solutions, and Roche Diagnostics International presented a poster during ISPOR 2024. The objective was to assess the…